PPH

Fund Description
The Market Vectors Pharmaceutical ETF (PPH) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the Market Vectors US Listed Pharmaceutical 25 Index (MVPPHTR). The Index is a rules-based index intended to track the overall performance of 25 of the largest U.S. listed, publicly traded pharmaceutical companies.
Fund Profile
Fund Name VanEck Vectors Pharmaceutical ETF
Fund Exchange Ticker PPH
Fund Sponsor Van Eck Associates Corporation
Fund ISIN US92189F6925
Net Expense Ratio 0.35 %
Fund Inception Date 20 December 2011
Fund Legal Structure ETF (Open end fund)
Exchange NASDAQ
Listing Country Code US
Fund Investment Objective
ETF Type Specific Global or ExUS Equities - Industry Sector
Asset Class Equities (Stocks)
Index Linked Passive
Index Name Market Vectors US Listed Pharmaceutical 25 Index
Index Provider Market Vectors
Currency Hedged No
Inverse / Leveraged Not Applicable
Developed / Emerging Developed Market Funds
Market Capitalization Range Broad Market / Multi-Cap
Growth Value Core / Blend
Continent Not Applicable
Key Statistics
Return As of Date 16 January 2019
Asset Under Management 230.42 Million (USD)
1 Month Total Return -1.64 %
Year To Date Return 4.18 %
1 Year Total Return -7.35 %
3 Year Annualized Total Return -0.33 %
NAV 57.06
Share Outstanding 4,038,140
Top 10 Holdings (16 January 2019)
Constituent Name Constituent Ticker Constituent Type Weighting
ELI LILLY & CO LLY EQUI 0.0539
GLAXOSMITHKLINE PLC-SPON ADR GSK EQUI 0.0538
NOVO NORDISK A/S-B NOVOB EQUI 0.0538
NOVARTIS AG-REG NOVN EQUI 0.0527
ABBVIE INC ABBV EQUI 0.051
MERCK & CO. INC. MRK EQUI 0.0505
PFIZER INC PFE EQUI 0.0503
SANOFI SAN EQUI 0.0493
ASTRAZENECA PLC-SPONS ADR AZN EQUI 0.0486
MCKESSON CORP MCK EQUI 0.0476